medline.ch Onkologie Urologische Tumoren

	Intra-corporeal robot-assisted versus open radical cystectomy: a meta-analysis. World J Urol Gan L, Wu J, Li Z, Cao H, Wang H, Li Y, Sun Z, Wang W. PMID: 42525253 [PubMed - indexed for MEDLINE]
	Global Dual Incidence-Mortality Patterns of Prostate Cancer Across SDI Regions, 1990-2021: A Cross-Sectional Study Based on Global Burden of Disease 2021. Health Sci Rep Ma Z, Wang C, Zhang Q, Lu Z, Chen D, Zhang X, Wang Y. PMID: 42524350 [PubMed - in process]
	Programmed cell death mechanisms of traditional plant medicine in prostate cancer therapy. Front Immunol Zhang Y, Qin S, Wang Y, Xu Y, Zhu Y. PMID: 42523794 [PubMed - indexed for MEDLINE]
	Feasibility and Safety of Repeat Robot-Assisted Partial Nephrectomy for Ipsilateral Local Recurrence: A Case Series. Int J Urol Yukimatsu N, Yamasaki T, Matsue T, Yamamoto S, Otoshi T, Kato M, Uchida J. PMID: 42522975 [PubMed - indexed for MEDLINE]
	Arginase 2 Downregulation in High-Grade Prostate Adenocarcinoma and Its Spatial Inverse Association with Tumor-Infiltrating Lymphocytes. Asian Pac J Cancer Prev Kaharuddin AB, Cangara MH, Miskad UA, Wahid S, Achmad D, Nelwan BJ. PMID: 42522834 [PubMed - indexed for MEDLINE]
	Superiority of Adjuvant Hyperfractionated Radiotherapy Over Chemotherapy Following Radical Cystectomy. Asian Pac J Cancer Prev Salah Ibrahim A, Gamal DA, Hadia A, Hasaballah A. PMID: 42522819 [PubMed - indexed for MEDLINE]
	The Impact of Dutasteride Treatment on Subsequent Multiparametric Prostate Magnetic Resonance Imaging Sequences and PI-RADS Score in Patients With PI-RADS 3 Lesions in the Transitional Zone. Int J Urol Sekkeli S, Erbin A, Erdal FS, Gursoy E, Dizdaroglu C, Turkay R. PMID: 42522546 [PubMed - indexed for MEDLINE]
	Preoperative Tumor Shape Irregularity Is Associated With Pathological Upstaging to pT3 in Clinical T1 Renal Cell Carcinoma Treated With Partial or Radical Nephrectomy. Int J Urol Yamashita S, Yamamoto H, Tosuji H, Mashima N, Iwahashi Y, Kawabata H, Muraoka S, Wakamiya T, Kohjimoto Y. PMID: 42522538 [PubMed - indexed for MEDLINE]
	Matching-adjusted indirect comparison of enzalutamide versus apalutamide with androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer. Future Oncol Azad AA, Pandya BJ, Bhadauria HS, Berrak E, Daki V, Martins P, Kim J, Serikoff A, Baio G, Armstrong AJ. PMID: 42522424 [PubMed - as supplied by publisher]
	[Hereditary leiomyomatosis and renal cell carcinoma syndrome : Pathological features, diagnostics, and clinical implications]. Pathologie (Heidelb) Erber R, Hartmann A. PMID: 42521857 [PubMed - as supplied by publisher]
	Telomere stability pathway genes as predictors of susceptibility and prognosis in urothelial bladder cancer: review and bioinformatics analyses. J Toxicol Environ Health B Crit Rev da Silva IM, Rocha LMO, de Andrade QG, de Lima LVA, Vacario BGL, de Almeida TM, Maraslis FT, Martinez-López W, Debia N, de Sousa AA, de Castro E Sousa JM, Serpeloni JM. PMID: 42521654 [PubMed - as supplied by publisher]
	Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis. Eur Urol Kishan AU, Sun Y, Parker CC, Sargos P, Sydes M, Chabaud S, Brihoum M, Supiot S, Latorzeff I, Guerif S, Kalbasi TR, Steinberg ML, Valle LF, Taparra K, Farrell MJ, Shoag JE, Garcia JA, Brown JR, Rettig MB, Singer AE, Baclig N, Reiter RE, Eggener S, Brisbane W, Roy S, Jia AY, Ma TM, Nickols NG, Efstathiou JA, Dignam JJ, Seiferheld WF, Pollack A, Sandler HM, Nguyen PL, Pommier P, Spratt DE. PMID: 42521517 [PubMed - as supplied by publisher]
	Assessing the Feasibility of a Self-Management Intervention for Individuals With Advanced Prostate Cancer and Comorbid Type II Diabetes Mellitus. Cancer Med Shaver AL, Steinbock-Malfer C, Tester W, Mille P, Kelly WK, Zarrabi KK, Lallas CD, Shah M, DiMarco R, Brand E, Brown S, Sharma S, Nikita N, Cogen C, Keith SW, Lu-Yao G. PMID: 42521319 [PubMed - indexed for MEDLINE]
	Squamous Cell Carcinoma of the Bladder: Current Evidence, Therapeutic Challenges, and Research Perspectives from the French AVENTUR Group. Crit Rev Oncol Hematol Mercier J, Cornillon P, Barthélémy P, Leon P, Fontugne J, Guimas V, Bouleftour W, Olivier L, Affi R, Pouessel D, Culine S, Roumiguié M, Mahammedi H, Thibault C, Moinard-Butot F. PMID: 42520864 [PubMed - as supplied by publisher]
	Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Neoadjuvant and Adjuvant Strategies. Clin Oncol (R Coll Radiol) Suartz CV, Huber IMT, Brito PHS, de Lima RD, Freitas APS, de Almeida LS, Liebl B, Reis GBB, Sant'Anna PVH, de Campos VDF, Mota JM, Reis LO, Nahas WC, Dener MC, Shahrour W, Shabana W, Ribeiro-Filho LA. PMID: 42520756 [PubMed - as supplied by publisher]
	Carbonic anhydrase IX-targeted small molecule radiopharmaceuticals: A review of their role in clear cell renal cell carcinoma theranostics. Nucl Med Biol Liu Y, Zhang M, Ge X, Meng X. PMID: 42520690 [PubMed - as supplied by publisher]
	Urinary biomarkers in muscle-invasive bladder cancer: Current state and open opportunities for neoadjuvant chemotherapy response prediction and patient stratification. Biomed Pharmacother de Miguel-García G, Ruiz de Porras V, Font-Morón M, Font A, Borràs FE, Clos-Sansalvador M. PMID: 42520639 [PubMed - as supplied by publisher]
	Comparison of biparametric and multiparametric prostate MRI to assess extraprostatic tumor extension. Eur J Radiol Bischoff LM, Schmidt CJ, Endler C, Bernhardt M, Kristiansen G, Ellinger J, Hauser S, Ohlmann CH, Luetkens JA, Ritter M, Mesropyan N, Krausewitz P, Isaak A. PMID: 42520381 [PubMed - as supplied by publisher]
	Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer. J Nucl Med Miller SR, Chung DH, Gonzalez RT, Jackson WC, Caram MEV, Tsao PA, Stensland K, Gulati R, Shah Y, Wale D, Elliott D, Caverly T, Hofer TP, Saini S, Green MD, Schipper M, Dess RT, Bryant AK. PMID: 42520266 [PubMed - indexed for MEDLINE]
	Early outcomes after focal high-dose-rate brachytherapy in low- and favorable intermediate-risk prostate cancer: promising early results from a prospective randomized trial. Open Med (Wars) Jonusas J, Patasius A, Trakymas M, Akelaitis K, Dziugelis M, Burkanas M, Venius J, Smailyte G, Kincius M. PMID: 42519814 [PubMed]

Artikel 1 - 20 / 180379

Seite 1 von 9019

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung